The utility of animal models in hiPSC-based studies of autism spectrum disorder: a systematic review.
- 1Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
- 2Department of Pathology, Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo, São Paulo, SP, Brazil.
Abstract
Introduction
Autism spectrum disorder is a highly prevalent and heritable neurodevelopmental condition. To investigate its pathogenesis, genetic and non-genetic animal models have been developed. However, no animal model can fully capture the human-specific characteristics and genetic complexity of autism spectrum disorder. In this context, human induced pluripotent stem cell (hiPSC) derived models have emerged as powerful tools in autism spectrum disorder research, offering the potential to reduce or replace animal experiments. Despite this potential, many hiPSC-based studies still incorporate animal use.Objective
To analyze the use of animals in hiPSC-based studies of autism spectrum disorder, with the aim of assessing the necessity of their inclusion and their contribution to our understanding of disease mechanisms.Methods
Following the PRISMA guidelines, we searched PubMed, Scopus, and Web of Science for articles published between 2009 and 2024 using the search terms "autism", "ASD", and "autism spectrum disorder" combined with "iPSC", "induced pluripotent stem cells and "organoid*".Results
A total of 207 studies using hiPSCs to investigate Autism spectrum disorder were identified. Of these, 79 studies (38.16%) also involved animals or animal-derived cells. While nearly half of these studies used autism spectrum disorder animal models to explore neurobiological mechanisms of the disorder, the remaining studies employed animals for purposes not directly related to understanding autism spectrum disorder pathophysiology. These included teratoma formation assays to validate hiPSC pluripotency and the extraction of primary astrocytes for co-culture with hiPSC-derived neurons, an approach that may introduce confounding variables.Conclusion
Our review highlights the frequent and, in some cases, unnecessary use of animals in hiPSC-based studies of autism spectrum disorder.
Related
- Utility of Blood Neutrophil to Diagnose Bacterial Infections under Satralizumab Treatment for Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Report of Two Cases
- The effect of exercise on regulatory T cells: A systematic review of human and animal studies with future perspectives and methodological recommendations
- Prevalence and risk factors of elopement behavior in children and adolescents with autism spectrum disorder: a systematic review and meta-analysis
- Antidepressant effects of artemisinin and its derivatives: a systematic review and meta-analysis of randomized controlled animal studies.
- Neuroimaging Studies of Bipolar Disorder With Suicide Attempts: A Systematic Review
BibTeX
@article{yokotamoreno2026utility,
title = {{The utility of animal models in hiPSC-based studies of autism spectrum disorder: a systematic review.}},
author = {Bruno Yukio Yokota-Moreno and André Luiz Teles E Silva and Isabella de Sousa Nóbrega and Lucas Barbosa Rossetti and Paulo César Maiorka and Andréa Laurato Sertié and Claudia Madalena Cabrera Mori},
journal = {Einstein (Sao Paulo, Brazil)},
year = {2026},
month = oct,
doi = {10.31744/einstein_journal/2026rw1868},
url = {https://europepmc.org/article/MED/42848640},
note = {CC BY},
}
RIS
TY - JOUR
TI - The utility of animal models in hiPSC-based studies of autism spectrum disorder: a systematic review.
AU - Bruno Yukio Yokota-Moreno
AU - André Luiz Teles E Silva
AU - Isabella de Sousa Nóbrega
AU - Lucas Barbosa Rossetti
AU - Paulo César Maiorka
AU - Andréa Laurato Sertié
AU - Claudia Madalena Cabrera Mori
PY - 2026
DA - 2026/10/05
JO - Einstein (Sao Paulo, Brazil)
DO - 10.31744/einstein_journal/2026rw1868
UR - https://europepmc.org/article/MED/42848640
AB - Introduction Autism spectrum disorder is a highly prevalent and heritable neurodevelopmental condition. To investigate its pathogenesis, genetic and non-genetic animal models have been developed. However, no animal model can fully capture the human-specific characteristics and genetic complexity of autism spectrum disorder. In this context, human induced pluripotent stem cell (hiPSC) derived models have emerged as powerful tools in autism spectrum disorder research, offering the potential to reduce or replace animal experiments. Despite this potential, many hiPSC-based studies still incorporate animal use.Objective To analyze the use of animals in hiPSC-based studies of autism spectrum disorder, with the aim of assessing the necessity of their inclusion and their contribution to our understanding of disease mechanisms.Methods Following the PRISMA guidelines, we searched PubMed, Scopus, and Web of Science for articles published between 2009 and 2024 using the search terms "autism", "ASD", and "autism spectrum disorder" combined with "iPSC", "induced pluripotent stem cells and "organoid*".Results A total of 207 studies using hiPSCs to investigate Autism spectrum disorder were identified. Of these, 79 studies (38.16%) also involved animals or animal-derived cells. While nearly half of these studies used autism spectrum disorder animal models to explore neurobiological mechanisms of the disorder, the remaining studies employed animals for purposes not directly related to understanding autism spectrum disorder pathophysiology. These included teratoma formation assays to validate hiPSC pluripotency and the extraction of primary astrocytes for co-culture with hiPSC-derived neurons, an approach that may introduce confounding variables.Conclusion Our review highlights the frequent and, in some cases, unnecessary use of animals in hiPSC-based studies of autism spectrum disorder.
SN - 1679-4508
SN - 2317-6385
ER -